35th week of 2017 patent applcation highlights part 9 |
Patent application number | Title | Published |
20170246225 | ORAL COMPOSITION CONTAINING BIFIDOBACTERIA AND CRUCIFEROUS VEGETABLE | 2017-08-31 |
20170246226 | COMPOSITIONS AND METHOD FOR TREATMENT AND PROPHYLAXIS OF INFLAMMATORY BOWEL DISEASE | 2017-08-31 |
20170246227 | COMBINATION COMPRISING SPIRULINA AND PALMITOYLETHANOLAMIDE AND/OR SALTS OR PHARMACEUTICALLY ACCEPTABLE DERIVATIVES THEREOF AND THEIR FORMULATIONS, FOR USE IN THE PREVENTION AND/OR IN THE TREATMENT OF HYPERACTIVATED TISSUE CONDITIONS | 2017-08-31 |
20170246228 | METHOD FOR SUPPRESSING PROLIFERATION AND/OR INDUCING APOPTOSIS OF CANCER CELLS | 2017-08-31 |
20170246229 | EXTRACTS OF NANNOCHLOROPSIS SP. AND THEIR APPLICATIONS | 2017-08-31 |
20170246230 | PHARMACEUTICAL COMPOSITION FOR TREATING INFERTILITY, AND PREPARATION METHOD AND USE THEREOF | 2017-08-31 |
20170246231 | METHODS FOR TREATING NEUROLOGICAL DISORDERS USING NUTRIENT COMPOSITIONS | 2017-08-31 |
20170246232 | TOPICAL HEALING AND SCAR TREATMENT COMPOSITION | 2017-08-31 |
20170246233 | METHOD OF DECREASING BLOOD SUGAR | 2017-08-31 |
20170246234 | METHODS OF USING WATER SOLUBLE TEA EXTRACTS TO IMPROVE MUSCLE PERFORMANCE, STRESS RESPONSE, AND RECOVERY FOLLOWING EXERCISE | 2017-08-31 |
20170246235 | GREEN TEA COMPOSITIONS | 2017-08-31 |
20170246236 | METHODS AND COMPOSITIONS FOR ENHANCED DELIVERY OF COMPOUNDS | 2017-08-31 |
20170246237 | SELF-ASSEMBLING TRIPEPTIDES | 2017-08-31 |
20170246238 | NEUROKININ 1 RECEPTOR AGONIST MEDIATED PROTECTION OF THE EYE | 2017-08-31 |
20170246239 | ANTI-BLEPHARITIS COMPOSITIONS AND THEIR USE | 2017-08-31 |
20170246240 | Antibacterial Peptide and Method of Treatment Using the Antibacterial Peptide | 2017-08-31 |
20170246242 | PHARMACEUTICAL CYCLOSPORIN COMPOSITIONS | 2017-08-31 |
20170246243 | BIORESORBABLE SCAFFOLD FOR TREATMENT OF BIFURCATION LESION | 2017-08-31 |
20170246244 | Charged Nutritive Proteins and Methods | 2017-08-31 |
20170246245 | NOVEL PHARMACEUTICAL COMPOSITION FOR TREATING ALZHEIMER'S DISEASE | 2017-08-31 |
20170246246 | COMPOSITIONS AND METHODS FOR INHIBITING INTERCELLULAR INTERACTIONS | 2017-08-31 |
20170246247 | Use Of SCO-Spondin Peptides For Inhibiting Or Preventing Neuronal Apoptosis Mediated By Cell Death Receptor Ligands | 2017-08-31 |
20170246248 | OLIGOPEPTIDIC COMPOUNDS AND USES THEREOF | 2017-08-31 |
20170246249 | Compositions and Methods of Use for Treating Metabolic Disorders | 2017-08-31 |
20170246250 | ELUTING MATRIX AND USES THEREOF | 2017-08-31 |
20170246252 | Methods of Using Interleukin-10 for Treating Diseases and Disorders | 2017-08-31 |
20170246253 | Interleukin-15 Compositions and Uses Thereof | 2017-08-31 |
20170246254 | LYOPHILISED PHARMACEUTICAL FORMULATION AND ITS USE | 2017-08-31 |
20170246255 | Stable Analogs of Peptide and Polypeptide Therapeutics | 2017-08-31 |
20170246256 | METHODS OF ADMINISTERING HEPCIDIN | 2017-08-31 |
20170246257 | POSTPRANDIAL GASTROKINETIC AGENT | 2017-08-31 |
20170246258 | AGENT, PRODUCT AND USE | 2017-08-31 |
20170246259 | Compositions and Methods of Using Interleukin-4 Induced Gene 1 (IL-4I1) | 2017-08-31 |
20170246260 | MODIFIED ANTIVIRAL NUCLEASE | 2017-08-31 |
20170246261 | ANTIVIRAL TREATMENT WITH LOW IMMUNOGENICITY | 2017-08-31 |
20170246262 | COMPOSITIONS AND METHODS FOR PROTECTING AGAINST AIRBORNE PATHOGENS AND IRRITANTS | 2017-08-31 |
20170246263 | LYSOSOMAL TARGETING AND USES THEREOF | 2017-08-31 |
20170246264 | SOLUBLE HYALURONIDASE GLYCOPROTEIN (sHASEGP), PROCESS FOR PREPARING THE SAME, USES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEREOF | 2017-08-31 |
20170246265 | PHARMACEUTICAL PREPARATIONS FOR ATTENTION DEFICIT DISORDER, ATTENTION DEFICIT HYPERACTIVITY DISORDER AND OTHER ASSOCIATED DISORDERS | 2017-08-31 |
20170246266 | Novel Cell Penetrating Peptide, Conjugate Thereof with Botulinum Toxin, and Use Thereof | 2017-08-31 |
20170246267 | CHOLINERGIC ANTAGONISM AS AN ADJUNCT TO CANCER THERAPY | 2017-08-31 |
20170246268 | Longevity Enhancement Induced by Repetitive Injections of Botulinum Toxin (Centurion Effect) | 2017-08-31 |
20170246269 | METHODS OF TREATING OR PREVENTING PERIODONTITIS AND DISEASES ASSOCIATED WITH PERIODONTITIS | 2017-08-31 |
20170246270 | PEPTIDIC CHIMERIC ANTIGEN RECEPTOR T CELL SWITCHES AND USES THEREOF | 2017-08-31 |
20170246271 | INNATE IMMUNE MODULATING MOLECULE COMPLEX FOR THE ACTIVATION OF THE INNATE IMMUNE SYSTEM OF AQUATIC ANIMALS AND METHODS THEREFOR | 2017-08-31 |
20170246272 | COMPOSITIONS AND METHODS FOR TREATING B CELL MEDIATED AUTOIMMUNE DISORDERS | 2017-08-31 |
20170246273 | RECOMBINANT LISTERIA STRAIN EXPRESSING HETEROLOGOUS ANTIGEN FUSION PROTEINS AND METHODS OF USE THEREOF | 2017-08-31 |
20170246274 | IMMUNOGENIC POLYPEPTIDE COCKTAIL FOR THE TREATMENT OF MEDULLARY THYROID CARCINOMA | 2017-08-31 |
20170246275 | CANCER IMMUNE-BASED THERAPY | 2017-08-31 |
20170246276 | YEAST-BRACHYURY IMMUNOTHERAPEUTIC COMPOSITIONS | 2017-08-31 |
20170246277 | REAGENTS AND METHODS FOR IDENTIFYING, ENRICHING, AND/OR EXPANDING ANTIGEN-SPECIFIC T CELLS | 2017-08-31 |
20170246278 | BIPARTITE AND TRIPARTITE SIGNALING IMMUNE CELLS | 2017-08-31 |
20170246279 | COMPOSITIONS AND METHODS FOR BOOSTING THE EFFICACY OF ADOPTIVE CELLULAR IMMUNOTHERAPY | 2017-08-31 |
20170246280 | Modified Immunization Vectors | 2017-08-31 |
20170246281 | PATHOGEN VACCINES AND METHODS OF PRODUCING AND USING THE SAME | 2017-08-31 |
20170246282 | MULTIVALENT BRUCELLA VACCINE FOR PROTECTION AGAINST MYCOBACTERIAL INFECTIONS AND METHODS OF USING THE SAME | 2017-08-31 |
20170246283 | COMPOSITION FOR INDUCING PROLIFERATION OR ACCUMULATION OF REGULATORY T CELLS | 2017-08-31 |
20170246284 | STAPHYLOCOCCUS AUREUS MATERIALS AND METHODS | 2017-08-31 |
20170246285 | Conjugation of Streptococcal Capsular Saccharides | 2017-08-31 |
20170246286 | Attenuated Mannheimia haemolytica Vaccines and Methods of Making and Use | 2017-08-31 |
20170246287 | VACCINE COMPOSITION FOR TRANSDERMAL ADMINISTRATION | 2017-08-31 |
20170246288 | MULTILAMELLAR LIPID VESICLE COMPOSITIONS AND METHODS OF USE | 2017-08-31 |
20170246289 | Method of quickly producing antibodies against avian influenza and maintain antibody titer of duck | 2017-08-31 |
20170246290 | OIL-IN-WATER EMULSION INFLUENZA VACCINE | 2017-08-31 |
20170246291 | T20 CONSTRUCTS FOR ANTI-HIV (HUMAN IMMUNODEFICIENCY VIRUS) THERAPY AND/OR VACCINES | 2017-08-31 |
20170246292 | GENETICALLY STABLE RECOMBINANT MODIFIED VACCINIA ANKARA (RMVA) VACCINES AND METHODS OF PREPARATION THEREOF | 2017-08-31 |
20170246293 | SYNTHETIC LONG PEPTIDES (SLP) FOR THERAPEUTIC VACCINATION AGAINST HEPATITIS B VIRUS INFECTION | 2017-08-31 |
20170246294 | NANOEMULSION COMPOSITIONS FOR PREVENTING, SUPPRESSING OR ELIMINATING ALLERGIC AND INFLAMMATORY DISEASE | 2017-08-31 |
20170246295 | ALPHA-TOCOPHEROL-BASED ADJUVANTED SOLVENT FOR DNA VACCINES | 2017-08-31 |
20170246296 | INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF THREONYL-TRNA SYNTHETASES | 2017-08-31 |
20170246297 | ANTI-CD40 ANTIBODIES AND METHODS OF USE | 2017-08-31 |
20170246298 | METHODS AND COMPOSITIONS FOR CANCER TREATMENT AND TREATMENT SELECTION | 2017-08-31 |
20170246299 | COMPOSITIONS AND METHODS FOR TREATMENT OF PRE-CANCEROUS SKIN LESIONS | 2017-08-31 |
20170246300 | C5-C6-FUSED TRICYCLIC IMINOTHIADIAZINE DIOXIDE COMPOUNDS AS BACE INHIBITORS, COMPOSITIONS, AND THEIR USE | 2017-08-31 |
20170246301 | FATTY ACID CONJUGATES OF QUETIAPINE, PROCESS FOR MAKING AND USING THE SAME | 2017-08-31 |
20170246302 | POLYMER COATING COMPOSITIONS AND COATED PRODUCTS | 2017-08-31 |
20170246303 | NANOEMULSIONS | 2017-08-31 |
20170246304 | METHOD FOR INTRODUCING EXOGENOUS SUBSTANCE INTO CELL, AND MATERIAL USED IN SAID METHOD | 2017-08-31 |
20170246305 | mTORC1 INHIBITORS | 2017-08-31 |
20170246306 | DERIVATIVES OBTAINED FROM HYALURONIC ACID AND CARNOSINE | 2017-08-31 |
20170246307 | Amino Acid Conjugates of Quetiapine, Process for Making and Using the Same | 2017-08-31 |
20170246308 | Amino Acid Conjugates of Quetiapine, Process for Making and Using the Same | 2017-08-31 |
20170246309 | POLYOL-BASED OSMOTIC POLYDIXYLITOL POLYMER GENE TRANSPORTER AND USE THEREOF | 2017-08-31 |
20170246310 | VAR2CSA-DRUG CONJUGATES | 2017-08-31 |
20170246311 | PEPTIDES FOR BINDING ALTERNATIVELY ACTIVATED MACROPHAGES | 2017-08-31 |
20170246312 | NOVEL IMMUNOSTIMULATORY METHOD | 2017-08-31 |
20170246313 | AN IMPROVED PROCESS OF CONJUGATION AND NOVEL SYNTHETIC OLIGOSACCHARIDE- PROTEIN CONJUGATES OBTAINED THEREOF | 2017-08-31 |
20170246314 | Folate Receptor Binding Conjugates of Antifolates | 2017-08-31 |
20170246315 | THERAPEUTIC AGENTS AND USE THEREOF | 2017-08-31 |
20170246316 | COMPOSITE CONTAINING POLY(GLYCEROL SEBACATE) FILLER | 2017-08-31 |
20170246317 | DNA SEQUENCE, AND RECOMBINANT PREPARATION OF GROUP 4 MAJOR ALLERGENS FROM CEREALS | 2017-08-31 |
20170246318 | AFFENADENOVIRUS (GORILLA) OR ADENOVIRAL VECTORS AND METHODS OF USE | 2017-08-31 |
20170246319 | BIODEGRADABLE LIPIDS FOR DELIVERY OF NUCLEIC ACIDS | 2017-08-31 |
20170246320 | MUCUS PENETRATING GENE CARRIERS | 2017-08-31 |
20170246321 | Edible Plants Producing Bioengineered Micro-RNA for Gene Regulation Upon Ingestion | 2017-08-31 |
20170246322 | GUIDED INJECTIONS FOR AAV GENE TRANSFER TO MUSCLE | 2017-08-31 |
20170246323 | PYRROLIDONE DERIVATIVES, OLIGOMERS AND POLYMERS | 2017-08-31 |
20170246324 | PEPTIDE REAGENTS AND METHODS FOR DETECTION AND TARGETING OF DYSPLASIA, EARLY CANCER AND CANCER | 2017-08-31 |
20170246325 | Eukaryotic Cells with Artificial Endosymbionts for Multimodal Detection | 2017-08-31 |
20170246326 | Modular Imaging Agents Containing Amino Acids and Peptides | 2017-08-31 |